References
Real-world results from leading clinics and researchers
Nevisense is trusted by healthcare professionals and researchers around the world. With hundreds of thousands of measurements performed globally, the platform has proven its value in clinical practice, research and product development.
Backed by clinical evidence
Over 20 peer-reviewed publications confirm the clinical performance of Nevisense in melanoma and keratinocyte cancer detection, as well as skin barrier assessment. Studies have been conducted across Europe, the US and Asia, demonstrating broad clinical relevance.
Improving diagnostic accuracy
Clinical studies show that Nevisense significantly improves diagnostic sensitivity for melanoma, reduces unnecessary excisions, and adds value to dermoscopy-based evaluation.
Supporting research and innovation
Nevisense is increasingly used in academic studies focused on skin health, barrier function and the effects of dermatological treatments. Research groups value its repeatability, non-invasiveness and quantitative data output.
Used by leading institutions
Hospitals, dermatology clinics and research centers in Germany, Sweden, the US and other countries have integrated Nevisense into their workflows – citing improved diagnostic decision-making and streamlined patient care.
Get in touch with us
Have questions or want to learn more? Contact SciBase to discover how our solutions can support your work.